Drug factory · FDA FEI 2245277
Veranova, L.P.
2003 Nolte Drive, West Deptford, NJ, United States
Problems found, fixed voluntarily at FDA's last inspection, Jan 23, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
8 drug inspections on record since 2010: 4 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Acetaminophen and Benzhydrocodone | Makes the active ingredient | Zevra Therapeutics, Inc. | 70040-0145, 70040-0167, 70040-0189 |
| Buprenorphine and Naloxone | Makes the active ingredient | Indivior Inc. | 12496-1202, 12496-1204, 12496-1208 +1 |
| Methylphenidate | Makes the active ingredient | Amneal Pharmaceuticals | 0115-1800, 0115-1801, 0115-1802 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 23, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 15, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 8, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jan 31, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 5, 2016 | No problems found | Drug Quality Assurance | — |
| Oct 31, 2013 | No problems found | Drug Quality Assurance | — |
| Jun 21, 2012 | No problems found | Drug Quality Assurance | — |
| Jun 11, 2010 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.